This protocol is judged by an institutional overview board, an impartial team that assessments any medical trials involving human beings. If a review will involve a Schedule I drug, when the board approves the protocol as ethical, the scientists really need to make an application for an investigational new drug (IND) quantity from the FDA.Neverthel